drugset / Trial / NCT02549352
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the trial is to compare the short term efficacy of LEO 43204 gel with vehicle gel in AK on the balding scalp when applied topically once daily for 3 consecutive days as field treatment
Timeline
- Start
- 2015-11
- Primary completion
- 2016-09-22
- Completion
- 2017-08
Outcome
Met primary endpoint
registry analysis (superiority test); LEO 43204 0.037% Gel vs Vehicle Gel; p <0.001; Ratio of clearance rates 7.83 (95% CI 2.58 to 23.71) NCT02549352 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ingenol disoxate | Small molecule | — | Topical |